Tubulin polymerization-IN-2 is a potent anticancer agent targeting β-tubulin with an IC50 of 0.92 μM; it exhibits strong inhibitory activity against various leukemia, non-small cell lung cancer, renal cancer, prostate cancer, and breast cancer cell lines.